氯法齐明治疗结核病的临床应用指南

2020-05-05 中国防痨协会 中国防痨杂志.2020.42(5):409-417.

氯法齐明作为治疗耐药结核病的核心药物之一,由于缺乏规范性指导意见,中国防痨协会临床试验专业分会与《中国防痨杂志》编辑委员会组织相关专家制定本指南。本指南介绍了氯法齐明的分子结构与作用机制、药效学与药代

中文标题:

氯法齐明治疗结核病的临床应用指南

发布机构:

中国防痨协会

发布日期:

2020-05-05

简要介绍:

氯法齐明作为治疗耐药结核病的核心药物之一,由于缺乏规范性指导意见,中国防痨协会临床试验专业分会与《中国防痨杂志》编辑委员会组织相关专家制定本指南。本指南介绍了氯法齐明的分子结构与作用机制、药效学与药代动力学、耐药机制、不同类型人群的临床应用、适应证与禁忌证、剂量用法、化疗方案的制订,以及不良反应和临床应用注意事项等内容,以期对临床规范使用氯法齐明起到指导性作用。

 

相关资料下载:
[AttachmentFileName(sort=1, fileName=氯法齐明治疗结核病的临床应用指南.pdf)] GetToolGuiderByIdResponse(projectId=1, id=a29ef1c001910517, title=氯法齐明治疗结核病的临床应用指南, enTitle=, guiderFrom=中国防痨杂志.2020.42(5):409-417., authorId=0, author=, summary=氯法齐明作为治疗耐药结核病的核心药物之一,由于缺乏规范性指导意见,中国防痨协会临床试验专业分会与《中国防痨杂志》编辑委员会组织相关专家制定本指南。本指南介绍了氯法齐明的分子结构与作用机制、药效学与药代, cover=https://img.medsci.cn/2020528/1590671193046_2020535.jpg, journalId=0, articlesId=null, associationId=307, associationName=中国防痨协会, associationIntro=中国防痨协会成立于1933年10月21日,会址在上海。1950年从上海迁至北京,1953年8月在北京召开防痨工作者代表大会,70多年年来共召开了10次会员代表大会,先后由黄鼎臣、阚冠卿、戴志澄、张立兴、端木宏谨、王撷秀担任理事长。 协会编辑出版2种学术期刊,即《中国防痨杂志》和《国际结核病与肺部疾病杂志(中文版)》。1954年加入中国科协。1997年民政部关于社团清理整顿前,协会拥有全国及地方会员18000人,社团整顿后,中国防痨协会与各省、市、自治区地方防痨协会不存在垂直领导关系,但有业务指导关系,现全国31个省自治区直辖市均有防痨协会会员,现有会员近2000人,团体会员48个,3个专业委员会根据自己的专业特点,开展学术活动。, copyright=0, guiderPublishedTime=Tue May 05 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>氯法齐明作为治疗耐药结核病的核心药物之一,由于缺乏规范性指导意见,中国防痨协会临床试验专业分会与《中国防痨杂志》编辑委员会组织相关专家制定本指南。本指南介绍了氯法齐明的分子结构与作用机制、药效学与药代动力学、耐药机制、不同类型人群的临床应用、适应证与禁忌证、剂量用法、化疗方案的制订,以及不良反应和临床应用注意事项等内容,以期对临床规范使用氯法齐明起到指导性作用。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=380, tagName=结核病), TagDto(tagId=50473, tagName=氯法齐明)], categoryList=[CategoryDto(categoryId=9, categoryName=感染, tenant=100), CategoryDto(categoryId=12, categoryName=呼吸, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=380, guiderKeyword=结核病, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3233, appHits=88, showAppHits=67, pcHits=461, showPcHits=3207, likes=0, shares=10, comments=8, approvalStatus=1, publishedTime=Thu May 28 22:13:02 CST 2020, publishedTimeString=2020-05-05, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Thu May 28 22:12:49 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Thu Jan 04 21:09:20 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=氯法齐明治疗结核病的临床应用指南.pdf)])
氯法齐明治疗结核病的临床应用指南.pdf
下载请点击:
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1222443, encodeId=2903122244351, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16895728910, createdName=自此烟雨落盛京, createdTime=Wed May 25 21:36:17 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=955309, encodeId=e17a955309dd, content=👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210408/d9c86e48dc104935b49018dbf151b489/3c5c9264eca7469e8954b4a1441c5dc3.jpg, createdBy=e7265478217, createdName=502淘气, createdTime=Thu Apr 08 21:42:42 CST 2021, time=2021-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917789, encodeId=083a91e789ff, content=太好了,立即转发, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1d65453855, createdName=ms9000000974543283, createdTime=Mon Jan 18 18:09:53 CST 2021, time=2021-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917593, encodeId=ec5791e5933c, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJjdkFuFT9DxkzjiaO5tOZlWvxUdRETwQ5UJ0YfHLz4PJtLpWPTfJjwYBRzhz9OXLQAPH9LYibmER8A/132, createdBy=5d2a5176562, createdName=146e9e94m10(暂无昵称), createdTime=Sun Jan 17 23:27:12 CST 2021, time=2021-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812217, encodeId=44f181221eb9, content=打卡, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3115397739, createdName=ms8000001170738760, createdTime=Sun Aug 23 05:04:07 CST 2020, time=2020-08-23, status=1, ipAttribution=)]
    2022-05-25 自此烟雨落盛京

    谢谢分享

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1222443, encodeId=2903122244351, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16895728910, createdName=自此烟雨落盛京, createdTime=Wed May 25 21:36:17 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=955309, encodeId=e17a955309dd, content=👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210408/d9c86e48dc104935b49018dbf151b489/3c5c9264eca7469e8954b4a1441c5dc3.jpg, createdBy=e7265478217, createdName=502淘气, createdTime=Thu Apr 08 21:42:42 CST 2021, time=2021-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917789, encodeId=083a91e789ff, content=太好了,立即转发, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1d65453855, createdName=ms9000000974543283, createdTime=Mon Jan 18 18:09:53 CST 2021, time=2021-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917593, encodeId=ec5791e5933c, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJjdkFuFT9DxkzjiaO5tOZlWvxUdRETwQ5UJ0YfHLz4PJtLpWPTfJjwYBRzhz9OXLQAPH9LYibmER8A/132, createdBy=5d2a5176562, createdName=146e9e94m10(暂无昵称), createdTime=Sun Jan 17 23:27:12 CST 2021, time=2021-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812217, encodeId=44f181221eb9, content=打卡, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3115397739, createdName=ms8000001170738760, createdTime=Sun Aug 23 05:04:07 CST 2020, time=2020-08-23, status=1, ipAttribution=)]
    2021-04-08 502淘气

    👍

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1222443, encodeId=2903122244351, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16895728910, createdName=自此烟雨落盛京, createdTime=Wed May 25 21:36:17 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=955309, encodeId=e17a955309dd, content=👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210408/d9c86e48dc104935b49018dbf151b489/3c5c9264eca7469e8954b4a1441c5dc3.jpg, createdBy=e7265478217, createdName=502淘气, createdTime=Thu Apr 08 21:42:42 CST 2021, time=2021-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917789, encodeId=083a91e789ff, content=太好了,立即转发, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1d65453855, createdName=ms9000000974543283, createdTime=Mon Jan 18 18:09:53 CST 2021, time=2021-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917593, encodeId=ec5791e5933c, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJjdkFuFT9DxkzjiaO5tOZlWvxUdRETwQ5UJ0YfHLz4PJtLpWPTfJjwYBRzhz9OXLQAPH9LYibmER8A/132, createdBy=5d2a5176562, createdName=146e9e94m10(暂无昵称), createdTime=Sun Jan 17 23:27:12 CST 2021, time=2021-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812217, encodeId=44f181221eb9, content=打卡, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3115397739, createdName=ms8000001170738760, createdTime=Sun Aug 23 05:04:07 CST 2020, time=2020-08-23, status=1, ipAttribution=)]
    2021-01-18 ms9000000974543283

    太好了,立即转发

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1222443, encodeId=2903122244351, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16895728910, createdName=自此烟雨落盛京, createdTime=Wed May 25 21:36:17 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=955309, encodeId=e17a955309dd, content=👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210408/d9c86e48dc104935b49018dbf151b489/3c5c9264eca7469e8954b4a1441c5dc3.jpg, createdBy=e7265478217, createdName=502淘气, createdTime=Thu Apr 08 21:42:42 CST 2021, time=2021-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917789, encodeId=083a91e789ff, content=太好了,立即转发, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1d65453855, createdName=ms9000000974543283, createdTime=Mon Jan 18 18:09:53 CST 2021, time=2021-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917593, encodeId=ec5791e5933c, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJjdkFuFT9DxkzjiaO5tOZlWvxUdRETwQ5UJ0YfHLz4PJtLpWPTfJjwYBRzhz9OXLQAPH9LYibmER8A/132, createdBy=5d2a5176562, createdName=146e9e94m10(暂无昵称), createdTime=Sun Jan 17 23:27:12 CST 2021, time=2021-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812217, encodeId=44f181221eb9, content=打卡, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3115397739, createdName=ms8000001170738760, createdTime=Sun Aug 23 05:04:07 CST 2020, time=2020-08-23, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1222443, encodeId=2903122244351, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16895728910, createdName=自此烟雨落盛京, createdTime=Wed May 25 21:36:17 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=955309, encodeId=e17a955309dd, content=👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210408/d9c86e48dc104935b49018dbf151b489/3c5c9264eca7469e8954b4a1441c5dc3.jpg, createdBy=e7265478217, createdName=502淘气, createdTime=Thu Apr 08 21:42:42 CST 2021, time=2021-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917789, encodeId=083a91e789ff, content=太好了,立即转发, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1d65453855, createdName=ms9000000974543283, createdTime=Mon Jan 18 18:09:53 CST 2021, time=2021-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917593, encodeId=ec5791e5933c, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJjdkFuFT9DxkzjiaO5tOZlWvxUdRETwQ5UJ0YfHLz4PJtLpWPTfJjwYBRzhz9OXLQAPH9LYibmER8A/132, createdBy=5d2a5176562, createdName=146e9e94m10(暂无昵称), createdTime=Sun Jan 17 23:27:12 CST 2021, time=2021-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812217, encodeId=44f181221eb9, content=打卡, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3115397739, createdName=ms8000001170738760, createdTime=Sun Aug 23 05:04:07 CST 2020, time=2020-08-23, status=1, ipAttribution=)]
    2020-08-23 ms8000001170738760

    打卡

    0